Pharmaceutical Division
Tafamidis Meglumine
Tafamidis Meglumine is the meglumine salt form used for TTR amyloidosis treatment.
Transthyretin amyloidosisCAS 594839-89-1
Quality Assured
TTR stabilizer
Bulk Supply
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Tafamidis Meglumine – CAS 594839-89-1
CAS Number
594839-89-1
Category
Transthyretin amyloidosis
Therapeutic Class
TTR stabilizer
Description
Tafamidis Meglumine is the meglumine salt form used for TTR amyloidosis treatment.
Applications
- TTR amyloidosis
- Polyneuropathy treatment
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.